2‐Mercaptonicotinoyl glycine prevents UV‐induced skin darkening and delayed tanning in healthy subjects: A randomized controlled clinical study
Background Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2‐mercaptonicotinoyl glycine (2‐MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugatio...
Saved in:
Published in | Journal of cosmetic dermatology Vol. 23; no. 5; pp. 1745 - 1752 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.05.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2‐mercaptonicotinoyl glycine (2‐MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugation of the thiol group of 2‐MNG to melanin precursors.
Objective
To evaluate 2‐MNG in preventing both mechanisms in vivo.
Methods
In a randomized, intra‐individual and controlled study, 33 subjects with melanin‐rich skin were exposed to UV daylight on designated areas on the back and treated with a cosmetic formula containing 0.5% or 1% 2‐MNG alone or 0.5% 2‐MNG in association with lipohydroxy acid (LHA, 0.3%) plus Mexoryl‐SX (MSX, 1.5%). The respective vehicles were used as controls and 4‐n‐butyl‐resorcinol (4‐n‐BR, 2.5%) as a positive reference.
Results
2‐MNG alone significantly reduced immediate darkening and inhibited new melanin production when compared with vehicle, with higher performance at 1% than at 0.5%. 2‐MNG at 0.5% in association with LHA and MSX showed significantly higher performance than 2‐MNG 0.5% alone. 2‐MNG at 0.5% and 1% showed significantly better performance than 4‐n‐BR.
Conclusions
2‐MNG inhibited both UV‐induced skin pigmentation mechanisms in vivo. The association of 2‐MNG with LHA plus MSX showed the highest efficacy on melanin‐rich skin with pigmentation induced by UV exposure. |
---|---|
AbstractList | Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2-mercaptonicotinoyl glycine (2-MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugation of the thiol group of 2-MNG to melanin precursors.BACKGROUNDChronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2-mercaptonicotinoyl glycine (2-MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugation of the thiol group of 2-MNG to melanin precursors.To evaluate 2-MNG in preventing both mechanisms in vivo.OBJECTIVETo evaluate 2-MNG in preventing both mechanisms in vivo.In a randomized, intra-individual and controlled study, 33 subjects with melanin-rich skin were exposed to UV daylight on designated areas on the back and treated with a cosmetic formula containing 0.5% or 1% 2-MNG alone or 0.5% 2-MNG in association with lipohydroxy acid (LHA, 0.3%) plus Mexoryl-SX (MSX, 1.5%). The respective vehicles were used as controls and 4-n-butyl-resorcinol (4-n-BR, 2.5%) as a positive reference.METHODSIn a randomized, intra-individual and controlled study, 33 subjects with melanin-rich skin were exposed to UV daylight on designated areas on the back and treated with a cosmetic formula containing 0.5% or 1% 2-MNG alone or 0.5% 2-MNG in association with lipohydroxy acid (LHA, 0.3%) plus Mexoryl-SX (MSX, 1.5%). The respective vehicles were used as controls and 4-n-butyl-resorcinol (4-n-BR, 2.5%) as a positive reference.2-MNG alone significantly reduced immediate darkening and inhibited new melanin production when compared with vehicle, with higher performance at 1% than at 0.5%. 2-MNG at 0.5% in association with LHA and MSX showed significantly higher performance than 2-MNG 0.5% alone. 2-MNG at 0.5% and 1% showed significantly better performance than 4-n-BR.RESULTS2-MNG alone significantly reduced immediate darkening and inhibited new melanin production when compared with vehicle, with higher performance at 1% than at 0.5%. 2-MNG at 0.5% in association with LHA and MSX showed significantly higher performance than 2-MNG 0.5% alone. 2-MNG at 0.5% and 1% showed significantly better performance than 4-n-BR.2-MNG inhibited both UV-induced skin pigmentation mechanisms in vivo. The association of 2-MNG with LHA plus MSX showed the highest efficacy on melanin-rich skin with pigmentation induced by UV exposure.CONCLUSIONS2-MNG inhibited both UV-induced skin pigmentation mechanisms in vivo. The association of 2-MNG with LHA plus MSX showed the highest efficacy on melanin-rich skin with pigmentation induced by UV exposure. Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2-mercaptonicotinoyl glycine (2-MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugation of the thiol group of 2-MNG to melanin precursors. To evaluate 2-MNG in preventing both mechanisms in vivo. In a randomized, intra-individual and controlled study, 33 subjects with melanin-rich skin were exposed to UV daylight on designated areas on the back and treated with a cosmetic formula containing 0.5% or 1% 2-MNG alone or 0.5% 2-MNG in association with lipohydroxy acid (LHA, 0.3%) plus Mexoryl-SX (MSX, 1.5%). The respective vehicles were used as controls and 4-n-butyl-resorcinol (4-n-BR, 2.5%) as a positive reference. 2-MNG alone significantly reduced immediate darkening and inhibited new melanin production when compared with vehicle, with higher performance at 1% than at 0.5%. 2-MNG at 0.5% in association with LHA and MSX showed significantly higher performance than 2-MNG 0.5% alone. 2-MNG at 0.5% and 1% showed significantly better performance than 4-n-BR. 2-MNG inhibited both UV-induced skin pigmentation mechanisms in vivo. The association of 2-MNG with LHA plus MSX showed the highest efficacy on melanin-rich skin with pigmentation induced by UV exposure. Background Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2‐mercaptonicotinoyl glycine (2‐MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugation of the thiol group of 2‐MNG to melanin precursors. Objective To evaluate 2‐MNG in preventing both mechanisms in vivo. Methods In a randomized, intra‐individual and controlled study, 33 subjects with melanin‐rich skin were exposed to UV daylight on designated areas on the back and treated with a cosmetic formula containing 0.5% or 1% 2‐MNG alone or 0.5% 2‐MNG in association with lipohydroxy acid (LHA, 0.3%) plus Mexoryl‐SX (MSX, 1.5%). The respective vehicles were used as controls and 4‐n‐butyl‐resorcinol (4‐n‐BR, 2.5%) as a positive reference. Results 2‐MNG alone significantly reduced immediate darkening and inhibited new melanin production when compared with vehicle, with higher performance at 1% than at 0.5%. 2‐MNG at 0.5% in association with LHA and MSX showed significantly higher performance than 2‐MNG 0.5% alone. 2‐MNG at 0.5% and 1% showed significantly better performance than 4‐n‐BR. Conclusions 2‐MNG inhibited both UV‐induced skin pigmentation mechanisms in vivo. The association of 2‐MNG with LHA plus MSX showed the highest efficacy on melanin‐rich skin with pigmentation induced by UV exposure. |
Author | Sextius, P. Tachon, R. Jouni, H. Mainguene, E. Gaurav, K. Diridollou, S. Bourokba, N. Bastien, P. Dormael, R. |
Author_xml | – sequence: 1 givenname: R. orcidid: 0000-0001-7160-0570 surname: Dormael fullname: Dormael, R. email: romain.dedormael@loreal.com organization: L'Oréal Research and Innovation – sequence: 2 givenname: P. orcidid: 0000-0002-8710-6582 surname: Sextius fullname: Sextius, P. organization: L'Oréal Research and Innovation – sequence: 3 givenname: N. orcidid: 0000-0001-7429-7490 surname: Bourokba fullname: Bourokba, N. organization: L'Oréal Research and Innovation – sequence: 4 givenname: E. orcidid: 0000-0001-8402-9721 surname: Mainguene fullname: Mainguene, E. organization: L'Oréal Research and Innovation – sequence: 5 givenname: R. orcidid: 0000-0002-0997-7470 surname: Tachon fullname: Tachon, R. organization: L'Oréal Research and Innovation – sequence: 6 givenname: K. orcidid: 0000-0003-4142-7521 surname: Gaurav fullname: Gaurav, K. organization: L'Oréal Research and Innovation – sequence: 7 givenname: H. orcidid: 0000-0003-4641-3161 surname: Jouni fullname: Jouni, H. organization: L'Oréal Research and Innovation – sequence: 8 givenname: P. orcidid: 0000-0002-5602-5827 surname: Bastien fullname: Bastien, P. organization: L'Oréal Research and Innovation – sequence: 9 givenname: S. orcidid: 0000-0002-1272-1927 surname: Diridollou fullname: Diridollou, S. organization: L'Oréal Research and Innovation |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38372022$$D View this record in MEDLINE/PubMed |
BookMark | eNp90c1OGzEQAGCrApW_XniAyseqUsBeZ_96Q2kprUBcSK-rWXuSODh2antB2xOPUIk35ElwCOSAEL7Y8nwzlmf2yJZ1Fgk55OyIp3U8d1Id8SJj7APZ5cNSDDJe5Fubs2A7ZC-EOWO8rHn-keyISpQZy7Jdcp893P2_QC9hGZ3V0kVtXW_o1PRSW6RLjzdoY6DjPwlqqzqJioZrbakCf41W2ykFq6hCA30KRbBPdwnMEEyc9TR07RxlDN_oCfXJuoX-l6R0NnpnzOpodHobDA2xU_0B2Z6ACfjped8n49MfV6Ozwfnlz1-jk_OBFEXOBihAAVaqUJBDIVpsh3X6lQAoVd5OWK0QWl6jqBWfSFXmKItKpFAFIvFc7JMv67pL7_52GGKz0EGiMWDRdaHJ6qzKq6IaikQ_P9OuXaBqll4vwPfNSyMT-LoG0rsQPE42hLNmNaVmNaXmaUoJs1dY6ghRrxoC2rydwtcpt9pg_07x5vfl6Ps65xFAzqp2 |
CitedBy_id | crossref_primary_10_1111_jocd_16735 crossref_primary_10_1111_jdv_19910 crossref_primary_10_1111_pcmr_13168 crossref_primary_10_3390_cosmetics11060220 |
Cites_doi | 10.1271/bbb.69.2368 10.1111/exd.14260 10.1111/j.1529-8019.2007.00144.x 10.1111/phpp.12497 10.1111/jdv.18948 10.1111/bjd.12536 10.1002/em.2850260310 10.1097/01.DER.0000438425.56740.8a 10.1111/j.1473-2165.2007.00296.x 10.1111/srt.12877 10.1046/j.1524-4725.1999.08236.x 10.1111/j.1755-148X.2010.00764.x 10.1111/jdv.12051 10.1046/j.0022-202X.2004.22223.x 10.1111/j.1529-8019.2006.00085.x 10.1111/j.1600-0781.2008.00365.x 10.1111/j.1751-1097.2005.tb01456.x 10.1007/s00018-005-5054-y 10.1039/c2pp25152c |
ContentType | Journal Article |
Copyright | 2024 Loreal. published by Wiley Periodicals LLC. 2024 Loreal. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC. |
Copyright_xml | – notice: 2024 Loreal. published by Wiley Periodicals LLC. – notice: 2024 Loreal. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/jocd.16200 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1473-2165 |
EndPage | 1752 |
ExternalDocumentID | 38372022 10_1111_jocd_16200 JOCD16200 |
Genre | article Randomized Controlled Trial Journal Article |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 1OC 24P 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 52M 52O 52T 52U 52V 52W 53G 5GY 5HH 5VS 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANHP AAONW AASGY AAXRX AAZKR ABCUV ABDBF ABJNI ABPVW ABUWG ABXGK ACAHQ ACBWZ ACCFJ ACCMX ACCZN ACGFS ACMXC ACPOU ACRPL ACUHS ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADPDF ADXAS ADZCM ADZMN AEEZP AEGXH AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFGKR AFKRA AFPWT AFZJQ AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DRFUL DRMAN DRSTM EAD EAP EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F21 F5P FEDTE FUBAC FYUFA G-S G.N GODZA H.X HF~ HMCUK HVGLF HZ~ IHE KBYEO LATKE LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N04 N05 NF~ O66 O9- OIG OVD OVEED P2P P2W P2X P2Z P4B P4D PIMPY Q.N QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 UKHRP V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WVDHM YFH YUY ZZTAW ~IA ~WT AAYXX AGQPQ CITATION PHGZM PHGZT AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c3650-e3adae8d6da5a63beb497203aa7d5bf09deab19e39d1fcd75ec683d5b8a363b53 |
IEDL.DBID | 24P |
ISSN | 1473-2130 1473-2165 |
IngestDate | Fri Jul 11 04:23:23 EDT 2025 Mon Jul 21 06:04:54 EDT 2025 Tue Jul 01 02:37:53 EDT 2025 Thu Apr 24 22:57:51 EDT 2025 Wed Jan 22 17:19:32 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | mercaptoniacinamide (2‐MNG) topical anti‐pigmenting anti‐oxidation |
Language | English |
License | Attribution 2024 Loreal. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3650-e3adae8d6da5a63beb497203aa7d5bf09deab19e39d1fcd75ec683d5b8a363b53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0002-0997-7470 0000-0003-4641-3161 0000-0002-1272-1927 0000-0001-7160-0570 0000-0002-5602-5827 0000-0003-4142-7521 0000-0001-8402-9721 0000-0001-7429-7490 0000-0002-8710-6582 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjocd.16200 |
PMID | 38372022 |
PQID | 2928586843 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2928586843 pubmed_primary_38372022 crossref_primary_10_1111_jocd_16200 crossref_citationtrail_10_1111_jocd_16200 wiley_primary_10_1111_jocd_16200_JOCD16200 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2024 2024-05-00 2024-May 20240501 |
PublicationDateYYYYMMDD | 2024-05-01 |
PublicationDate_xml | – month: 05 year: 2024 text: May 2024 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of cosmetic dermatology |
PublicationTitleAlternate | J Cosmet Dermatol |
PublicationYear | 2024 |
References | 2004; 122 2022; 2022 2013; 27 2023 1995; 26 2023; 37 2013; 12 2019; 35 2019; 12 1999; 25 2005; 62 2013; 169 2020; 26 2005; 75 2014; 25 2007; 6 2006; 19 2008; 24 2011; 24 2005; 81 2007; 20 2021; 30 2005; 69 e_1_2_13_13_1 e_1_2_13_25_1 e_1_2_13_14_1 e_1_2_13_24_1 e_1_2_13_15_1 e_1_2_13_16_1 e_1_2_13_21_1 e_1_2_13_10_1 e_1_2_13_20_1 e_1_2_13_23_1 e_1_2_13_22_1 e_1_2_13_9_1 e_1_2_13_8_1 e_1_2_13_7_1 e_1_2_13_6_1 Xing X (e_1_2_13_11_1) 2022; 2022 Phillips TJ (e_1_2_13_17_1) 2005; 75 e_1_2_13_5_1 e_1_2_13_4_1 e_1_2_13_3_1 e_1_2_13_2_1 e_1_2_13_18_1 Dormael R (e_1_2_13_12_1) 2019; 12 e_1_2_13_19_1 |
References_xml | – volume: 12 start-page: E53 issue: 2 year: 2019 end-page: E59 article-title: Vitamin C prevents ultraviolet‐induced pigmentation in healthy volunteers: Bayesian meta‐analysis results from 31 randomized controlled versus vehicle clinical studies publication-title: J Clin Aesthet Dermatol – volume: 26 start-page: 794 year: 2020 end-page: 803 article-title: In vivo multiphoton imaging for non‐invasive time course assessment of retinoids effects on human skin publication-title: Skin Res Technol – volume: 169 start-page: 41 issue: Suppl 3 year: 2013 end-page: 56 article-title: Facial hyperpigmentation: causes and treatment publication-title: Br J Dermatol – volume: 6 start-page: 59 issue: 1 year: 2007 end-page: 65 article-title: The use of hydroxy acids on the skin: characteristics of C8‐lipohydroxy acid publication-title: J Cosmet Dermatol – volume: 2022 issue: 18 year: 2022 article-title: Implications of oxidative stress in the pathogenesis and treatment of hyperpigmentation disorders publication-title: Oxidative Med Cell Longev – volume: 37 start-page: 3 issue: S4 year: 2023 end-page: 11 article-title: A precise analysis of the relative contribution of UVA1 and visible light colour domains in solar light‐induced skin pigmentation publication-title: J Eur Acad Dermatol Venereol – volume: 62 start-page: 1707 issue: 15 year: 2005 end-page: 1723 article-title: Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future publication-title: Cell Mol Life Sci – volume: 19 start-page: 280 issue: 5 year: 2006 end-page: 288 article-title: Retinoid therapy of pigmentary disorders publication-title: Dermatol Ther – volume: 25 start-page: 282 issue: 4 year: 1999 end-page: 284 article-title: Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid publication-title: Dermatologic Surg – volume: 20 start-page: 308 issue: 5 year: 2007 end-page: 313 article-title: Skin lightening preparations and the hydroquinone controversy publication-title: Dermatol Ther – volume: 75 start-page: 14 issue: 2 Suppl year: 2005 end-page: 22 article-title: An update on the safety and efficacy of topical retinoids publication-title: Cutis – volume: 12 start-page: 54 issue: 1 year: 2013 end-page: 64 article-title: Effects of ultraviolet radiation, visible light, and infrared radiation on erythema and pigmentation: a review publication-title: Photochem Photobiol Sci – volume: 24 start-page: 136 issue: 1 year: 2011 end-page: 147 article-title: The deceptive nature of UVA tanning versus the modest protective effects of UVB tanning on human skin publication-title: Pigment Cell Melanoma Res – volume: 26 start-page: 248 issue: 3 year: 1995 end-page: 254 article-title: Taurine and ellagic acid: two differently‐acting natural antioxidants publication-title: Environ Mol Mutagen – volume: 35 start-page: 387 issue: 6 year: 2019 end-page: 392 article-title: The dynamics of pigment reactions of human skin to ultraviolet a radiation publication-title: Photodermatol Photoimmunol Photomed – year: 2023 – volume: 25 start-page: e1 issue: 1 year: 2014 end-page: e5 article-title: Hydroquinone‐induced depigmentation: case report and review of the literature publication-title: Dermatitis – volume: 69 start-page: 2368 issue: 12 year: 2005 end-page: 2373 article-title: Inhibitory effect of an ellagic acid‐rich pomegranate extract on tyrosinase activity and ultraviolet‐induced pigmentation publication-title: Biosci Biotechnol Biochem – volume: 122 start-page: 503 issue: 2 year: 2004 end-page: 509 article-title: Involvement of photooxidation of melanogenic precursors in prolonged pigmentation induced by ultraviolet a publication-title: J Invest Dermatol – volume: 30 start-page: 560 issue: 4 year: 2021 end-page: 571 article-title: Skin pigmentation and its control: from ultraviolet radiation to stem cells publication-title: Exp Dermatol – volume: 27 start-page: 19 issue: Suppl. S1 year: 2013 end-page: 23 article-title: 4‐n‐butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation publication-title: J Eur Acad Dermatol Venereol – volume: 24 start-page: 164 issue: 4 year: 2008 end-page: 174 article-title: Sunscreens containing the broad‐spectrum UVA absorber, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results publication-title: Photodermatol Photoimmunol Photomed – volume: 81 start-page: 874 year: 2005 end-page: 878 article-title: Standard ultraviolet daylight for nonextreme exposure conditions publication-title: Photochem Photobiol – ident: e_1_2_13_14_1 doi: 10.1271/bbb.69.2368 – ident: e_1_2_13_2_1 doi: 10.1111/exd.14260 – ident: e_1_2_13_18_1 doi: 10.1111/j.1529-8019.2007.00144.x – ident: e_1_2_13_6_1 doi: 10.1111/phpp.12497 – ident: e_1_2_13_21_1 – ident: e_1_2_13_25_1 doi: 10.1111/jdv.18948 – ident: e_1_2_13_10_1 doi: 10.1111/bjd.12536 – ident: e_1_2_13_13_1 doi: 10.1002/em.2850260310 – ident: e_1_2_13_19_1 doi: 10.1097/01.DER.0000438425.56740.8a – ident: e_1_2_13_22_1 doi: 10.1111/j.1473-2165.2007.00296.x – ident: e_1_2_13_15_1 doi: 10.1111/srt.12877 – ident: e_1_2_13_8_1 doi: 10.1046/j.1524-4725.1999.08236.x – volume: 2022 issue: 18 year: 2022 ident: e_1_2_13_11_1 article-title: Implications of oxidative stress in the pathogenesis and treatment of hyperpigmentation disorders publication-title: Oxidative Med Cell Longev – ident: e_1_2_13_3_1 doi: 10.1111/j.1755-148X.2010.00764.x – ident: e_1_2_13_9_1 doi: 10.1111/jdv.12051 – ident: e_1_2_13_4_1 doi: 10.1046/j.0022-202X.2004.22223.x – ident: e_1_2_13_16_1 doi: 10.1111/j.1529-8019.2006.00085.x – volume: 75 start-page: 14 issue: 2 year: 2005 ident: e_1_2_13_17_1 article-title: An update on the safety and efficacy of topical retinoids publication-title: Cutis – ident: e_1_2_13_20_1 – volume: 12 start-page: E53 issue: 2 year: 2019 ident: e_1_2_13_12_1 article-title: Vitamin C prevents ultraviolet‐induced pigmentation in healthy volunteers: Bayesian meta‐analysis results from 31 randomized controlled versus vehicle clinical studies publication-title: J Clin Aesthet Dermatol – ident: e_1_2_13_23_1 doi: 10.1111/j.1600-0781.2008.00365.x – ident: e_1_2_13_24_1 doi: 10.1111/j.1751-1097.2005.tb01456.x – ident: e_1_2_13_7_1 doi: 10.1007/s00018-005-5054-y – ident: e_1_2_13_5_1 doi: 10.1039/c2pp25152c |
SSID | ssj0017915 |
Score | 2.3490536 |
Snippet | Background
Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule,... Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule,... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1745 |
SubjectTerms | Adult anti‐oxidation anti‐pigmenting Female Glycine - administration & dosage Glycine - analogs & derivatives Glycine - pharmacology Healthy Volunteers Humans Male Melanins - radiation effects mercaptoniacinamide (2‐MNG) Middle Aged Skin - drug effects Skin - metabolism Skin - radiation effects Skin Pigmentation - drug effects Skin Pigmentation - radiation effects Sunbathing topical Ultraviolet Rays - adverse effects Young Adult |
Title | 2‐Mercaptonicotinoyl glycine prevents UV‐induced skin darkening and delayed tanning in healthy subjects: A randomized controlled clinical study |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjocd.16200 https://www.ncbi.nlm.nih.gov/pubmed/38372022 https://www.proquest.com/docview/2928586843 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NatwwEB7SBEIvpW3Sdts0KCSXBFzWlmxLoZc0P4TAJiFkw96M5NGWpVt7ib2H7amPUOgb9kk6kr0moaXQixFobIM_j2ZGM_MJYM-mVhttooDsKQZC8CTQCsMgshRLKI1hX7re4cFlcj4UF6N4tAIfl70wDT9Et-HmNMOv107BtakeKnmZ44cwIZSfwJrrrXXM-ZG47nIIqfLnF4Qi5UFES3VLTurreLp7H5ujP3zMxy6rtzlnz-FZ6yyyowbdF7Bii5ewPmjT4RvwM_r1_cfA3ud6VjuK27KeFOViyj5PF06AzRp-pooN70iQom_CEVn1ZVIwdGU5bk-E6QKZo4pc0FTdnGDESKBpkFywam7cVk11yI4Y2TUsv06-kWRb4j51w7a5knmq2k0Ynp3eHp8H7SkLQc7JPQss16itxAR1rBNurBHK5Wa1TjE2475CQjNUlhOE4xzT2OaJ5DQlNSfxmL-C1aIs7BtgZPzHFG9rqcjNCmMrOUfso-CoZC6M6cH-8mNneUtB7k7CmGZdKELAZB6YHux2srOGeOOvUjtLzDLSC5fs0IUt51UWqUjGMpGC9-B1A2b3HBeVR-S89ODAo_uPF2QXV8cnfvT2f4TfwVN6gWgqI7dgtb6f2_fkvdRm2_-kdE1H6TasfTq9vL75DWzV8e4 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwEB5BkaAXVP4XWjCCC0ipNraT2L1VLdVSuoVDF_UW2RkvWrFNVk32sD31EZD6hjwJYyeNqEBI3Cx5Ekv5Mp7_GYC3LnPGGssjkqcYSSnSyGiMI-7IltAG46HytcPj43Q0kYenyWmXm-NrYdr-EL3DzXNGuK89g3uH9O9cXhW4HacE8224I1Oeeb7k8ksfRMh0GGAQy0xEnO7qrjtpSOTpn70pj_5QMm_qrEHoHGzA_U5bZLstvA_glisfwt1xFw9_BFf85-WPsTsvzKLxPW6rZlZWqzn7Nl95ArZoGzTVbPKVCMn8JiCR1d9nJUOfl-OdIsyUyHyvyBVtNe0II0YEbYXkitVL63019Q7bZSTYsDqbXRBll-M-98uuupKFXrWPYXLw4WRvFHVjFqJCkH4WOWHQOIUpmsSkwjortQ_OGpNhYqdDjQRnrJ0gDKcFZokrUiVoSxlB5Il4AmtlVbpnwEj6T8ngNkqTnhUnTgmBOEQpUKtCWjuAd9cfOy-6HuR-FMY8720RAiYPwAzgTU-7aDtv_JXq9TVmOTGGj3aY0lXLOueaq0SlSooBPG3B7N_jzXJO2ssA3gd0_3FAfvh5bz-snv8P8Su4NzoZH-VHH48_vYB1Oky2aZKbsNacL90WqTKNfRl-2F8tsvLZ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwEB61Rap6QS0_7baUGsEFpKBN7CR2xaVquyqFLT2wqLfIznjRiiVZNdnD9sQjIPGGfRLGTjaiAiH1ZsmTWMqX8cx4xt8AvLKp1UabKCB7ioEQPAm0wjCILMUSSmPYl-7u8PAiORuJ86v4agXeLe_CNPwQ3YGb0wy_XzsFn-H4TyUvc3wbJoTyKjzw2T7H6ywuuxxCqnz_glCkPIhoq27JSX0dT_fsXXP0l49512X1NmewCQ9bZ5EdNehuwYotHsH6sE2HP4Zf0e2Pn0N7netZ7Shuy3pSlIsp-zpdOAE2a_iZKjb6QoIUfROOyKpvk4KhK8txZyJMF8gcVeSCpuqmgxEjgeaC5IJVc-OOaqpDdsTIrmH5fXJDkm2J-9QN28uVzFPVPoHR4PTz8VnQdlkIck7uWWC5Rm0lJqhjnXBjjVAuN6t1irEZ9xUSmqGynCAc55jGNk8kpympOYnH_CmsFWVhd4CR8R9TvK2lIjcrjK3kHLGPgqOSuTCmB6-XHzvLWwpy1wljmnWhCAGTeWB68LKTnTXEG_-UerHELCO9cMkOXdhyXmWRimQsEyl4D7YbMLv3uKg8IuelB288uv9ZIDv_dHziR7v3ET6A9cuTQfbx_cWHPdigtURTJPkM1urrud0nR6Y2z_3_-hvV3PIL |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2-Mercaptonicotinoyl+glycine+prevents+UV-induced+skin+darkening+and+delayed+tanning+in+healthy+subjects%3A+A+randomized+controlled+clinical+study&rft.jtitle=Journal+of+cosmetic+dermatology&rft.au=de+Dormael%2C+R&rft.au=Sextius%2C+P&rft.au=Bourokba%2C+N&rft.au=Mainguene%2C+E&rft.date=2024-05-01&rft.issn=1473-2165&rft.eissn=1473-2165&rft.volume=23&rft.issue=5&rft.spage=1745&rft_id=info:doi/10.1111%2Fjocd.16200&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-2130&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-2130&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-2130&client=summon |